Corneal Biomechanics After SMILE, Femtosecond-Assisted LASIK, and Photorefractive Keratectomy: A Matched Comparison Study.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
01 03 2023
Historique:
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 22 3 2023
Statut: ppublish

Résumé

To evaluate the change in corneal stiffness after small incision lenticule extraction (SMILE), femtosecond laser-assisted in situ keratomileusis (FS-LASIK), and photorefractive keratectomy (PRK). Age, gender, spherical equivalent, and central corneal thickness (CCT)-matched cases undergoing SMILE with a 120-µ cap, FS-LASIK with a 110-µ flap, and PRK were enrolled. One-year change in the stress-strain index, stiffness parameter at first applanation, integrated inverse radius, deformation amplitude ratio at 2 mm, and deformation amplitude ratio at 1 mm were compared between the surgical groups by linear mixed-effect models. Within each surgical group, 120 eyes completed 1 year of follow-up. The residual stromal bed (RSB) thickness and (RSB/CCTpostop) were 348.1 ± 35.0 (0.74), 375.4 ± 31.0 (0.77) and 426.7 ± 2 µm (0.88) after SMILE, FS-LASIK, and PRK, respectively. The 1-year change in all biomechanical indices was significant, except the stress-strain index with PRK (P = 0.884). The change in all indices with SMILE were significantly greater than with FS-LASIK and with PRK (all P < 0.01), except the deformation amplitude ratio at 1 mm change between SMILE and FS-LASIK (P = 0.075). The changes in all indices with FS-LASIK were significantly greater than with PRK (all P < 0.05). Although SMILE preserves the greatest amount of anterior cornea with a cap thickness of 120 µ, this also produces the smallest RSB and the greatest decrease in stiffness. Thus, the RSB is shown to be the predominant determinant of stiffness decreases, rather than the preserved anterior cornea. We recommend using a thinner cap to achieve a thicker RSB and a lesser decrease in the corneal stiffness in the SMILE procedure. After refractive surgery, RSB is predominant determinant of stiffness decreases, rather than the preserved anterior cornea.

Identifiants

pubmed: 36928130
pii: 2785449
doi: 10.1167/tvst.12.3.12
pmc: PMC10029763
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12

Références

Sci Rep. 2018 Aug 22;8(1):12580
pubmed: 30135552
Arq Bras Oftalmol. 2013 Oct;76(5):278-81
pubmed: 24232940
Open Ophthalmol J. 2018 Jul 27;12:164-174
pubmed: 30123381
Acta Ophthalmol. 2019 Mar;97(2):127-136
pubmed: 30203530
Graefes Arch Clin Exp Ophthalmol. 2014 Aug;252(8):1329-35
pubmed: 24862302
J Refract Surg. 2013 Jul;29(7):454-60
pubmed: 23820227
BMC Ophthalmol. 2016 Jul 26;16:123
pubmed: 27457241
J Refract Surg. 2016 Aug 1;32(8):550-61
pubmed: 27505316
Int Ophthalmol Clin. 2016 Spring;56(2):127-39
pubmed: 26938343
J Cataract Refract Surg. 2019 Jun;45(6):778-788
pubmed: 30902432
Clin Ophthalmol. 2021 Apr 06;15:1409-1423
pubmed: 33854295
Transl Vis Sci Technol. 2021 Jul 1;10(8):15
pubmed: 34259803
J Cataract Refract Surg. 2014 Jun;40(6):971-80
pubmed: 24857440
Curr Eye Res. 2016 Jul;41(7):917-22
pubmed: 26554611
BMC Ophthalmol. 2019 Aug 1;19(1):167
pubmed: 31370817
Exp Eye Res. 2006 Oct;83(4):709-20
pubmed: 16720023
Curr Opin Ophthalmol. 2020 Jul;31(4):288-292
pubmed: 32398416
J Cataract Refract Surg. 2014 Jun;40(6):918-28
pubmed: 24726160
J Refract Surg. 2022 Feb;38(2):90-97
pubmed: 35156458
Cornea. 2009 Aug;28(7):765-9
pubmed: 19574911
Front Bioeng Biotechnol. 2022 Mar 31;10:834270
pubmed: 35433653
Annu Rev Biomed Eng. 2011 Aug 15;13:269-95
pubmed: 21568714
Front Bioeng Biotechnol. 2019 May 16;7:105
pubmed: 31157217
J Cataract Refract Surg. 2017 Dec;43(12):1495-1503
pubmed: 29335093
Eye Contact Lens. 2017 Nov;43(6):371-377
pubmed: 27243355
J Refract Surg. 2020 Feb 1;36(2):82-88
pubmed: 32032428
J Refract Surg. 2017 Jul 1;33(7):444-453
pubmed: 28681903
J Refract Surg. 2017 Apr 1;33(4):266-273
pubmed: 28407167

Auteurs

Hassan Hashemi (H)

Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran.

Cynthia J Roberts (CJ)

Department of Ophthalmology & Visual Sciences, Department of Biomedical Engineering, The Ohio State University, Columbus, OH, USA.

Ahmed Elsheikh (A)

School of Engineering, University of Liverpool, Liverpool, UK.
National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China.

Shiva Mehravaran (S)

School of Computer, Mathematical, and Natural Sciences, Morgan State University, Baltimore, MD, USA.

Parsa Panahi (P)

Noor Research Center for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran.

Soheila Asgari (S)

Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH